| [1] |
Ekstein SF, Wyles SP, Moran SL, et al. Keloids: a review of therapeutic management[J]. Int J Dermatol, 2021, 60(6): 661-671.
|
| [2] |
Delaleu J, Charvet E, Petit A. Keloid disease: review with clinical atlas. Part I: Definitions, history, epidemiology, clinics and diagnosis[J]. Ann Dermatol Venereol, 2023, 150(1): 3-15.
|
| [3] |
Barone N, Safran T, Vorstenbosch J, et al. Current advances in hypertrophic scar and keloid management[J]. Semin Plast Surg, 2021, 35(3): 145-152.
|
| [4] |
Chong Y, Park TH, Seo S, et al. Histomorphometric analysis of collagen architecture of auricular keloids in an Asian population[J]. Dermatol Surg, 2015, 41(3): 415-422.
|
| [5] |
臧梦青. 增生性瘢痕和瘢痕疙瘩的诊治现状[J]. 中华医学杂志，2023, 103(7): 469-472.
|
| [6] |
Ogawa R, Dohi T, Tosa M, et al. The latest strategy for keloid and hypertrophic scar prevention and treatment: the nippon medical school (NMS) protocol[J]. J Nippon Med Sch, 2021, 88(1): 2-9.
|
| [7] |
Lee HJ, Jang YJ. Recent understandings of biology, prophylaxis and treatment strategies for hypertrophic scars and keloids[J]. Int J Mol Sci, 2018, 19(3)：711.
|
| [8] |
Petrou IG, Nikou S, Madduri S, et al. The role of Hippo signaling pathway and ILK in the pathophysiology of human hypertrophic scars and keloids: an immunohistochemical investigation[J]. Cells, 2022, 11(21)：3426.
|
| [9] |
Aramaki-Hattori N, Okabe K, Hamada M, et al. Relationship between keloid formation and YAP/TAZ signaling[J]. Plast Reconstr Surg Glob Open, 2017, 5(6): e1357.
|
| [10] |
Zhu N, Yang R, Wang X, et al. The Hippo signaling pathway: from multiple signals to the hallmarks of cancers[J]. Acta Biochim Biophys Sin (Shanghai), 2023, 55(6): 904-913.
|
| [11] |
Fu M, Hu Y, Lan T, et al. The Hippo signalling pathway and its implications in human health and diseases[J]. Signal Transduct Target Ther, 2022, 7(1): 376.
|
| [12] |
Plouffe SW, Lin KC, Moore JL, et al. The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell[J]. J Biol Chem, 2018, 293(28): 11230-11240.
|
| [13] |
Zhao B, Tumaneng K, Guan KL. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal[J]. Nat Cell Biol, 2011, 13(8): 877-883.
|
| [14] |
Ma S, Meng Z, Chen R, et al. The Hippo pathway: biology and pathophysiology[J]. Annu Rev Biochem, 2019, 88: 577-604.
|
| [15] |
顾思佳，孙国壮，乔大伟，等. Hippo信号通路与结直肠癌[J]. 国际肿瘤学杂志，2019(5): 299-302.
|
| [16] |
Kim CL, Choi SH, Mo JS. Role of the Hippo pathway in fibrosis and cancer[J]. Cells, 2019, 8(5)：468.
|
| [17] |
Misra JR, Irvine KD. The Hippo signaling network and its biological functions[J]. Annu Rev Genet, 2018, 52: 65-87.
|
| [18] |
Zanconato F, Cordenonsi M, Piccolo S. YAP/TAZ at the roots of cancer[J]. Cancer Cell, 2016, 29(6): 783-803.
|
| [19] |
Halder G, Dupont S, Piccolo S. Transduction of mechanical and cytoskeletal cues by YAP and TAZ[J]. Nat Rev Mol Cell Biol, 2012, 13(9): 591-600.
|
| [20] |
蔡甲慧，荣光宏. YAP在胃癌进展中的作用机制及临床意义[J]. 国际肿瘤学杂志，2022(11): 687-691.
|
| [21] |
Donnes P, Hoglund A. Predicting protein subcellular localization: past, present, and future[J]. Genomics Proteomics Bioinformatics, 2004, 2(4): 209-215.
|
| [22] |
Kim J, Kwon H, Shin YK, et al. MAML1/2 promote YAP/TAZ nuclear localization and tumorigenesis[J]. Proc Natl Acad Sci U S A, 2020, 117(24): 13529-13540.
|
| [23] |
Lee MJ, Byun MR, Furutani-Seiki M, et al. YAP and TAZ regulate skin wound healing[J]. J Invest Dermatol, 2014, 134(2): 518-525.
|
| [24] |
Berry CE, Downer M, Morgan AG, et al. The effects of mechanical force on fibroblast behavior in cutaneous injury[J]. Front Surg, 2023, 10: 1167067.
|
| [25] |
Gao N, Lu L, Ma X, et al. Targeted inhibition of YAP/TAZ alters the biological behaviours of keloid fibroblasts[J]. Exp Dermatol, 2022, 31(3): 320-329.
|
| [26] |
Mia MM, Singh MK. New insights into Hippo/YAP signaling in fibrotic diseases[J]. Cells, 2022, 11(13)：2065.
|
| [27] |
Huang J, Heng S, Zhang W, et al. Dermal extracellular matrix molecules in skin development, homeostasis, wound regeneration and diseases[J]. Semin Cell Dev Biol, 2022, 128: 137-144.
|
| [28] |
杨浠，王思瑶，郝林琳，等．细胞外基质：对肿瘤发展和治疗的生物学效应[J]．肿瘤，2021，41(11)：792-802.
|
| [29] |
Ogawa R. Keloid and hypertrophic scars are the result of chronic inflammation in the reticular dermis[J]. Int J Mol Sci, 2017, 18(3)：606.
|
| [30] |
Dupont S, Morsut L, Aragona M, et al. Role of YAP/TAZ in mechanotransduction[J]. Nature, 2011, 474(7350): 179-183.
|
| [31] |
Dupont S. Role of YAP/TAZ in cell-matrix adhesion-mediated signalling and mechanotransduction[J]. Exp Cell Res, 2016, 343(1): 42-53.
|
| [32] |
Morikawa M, Derynck R, Miyazono K. TGF-beta and the TGF-beta family: context-dependent roles in cell and tissue physiology[J]. Cold Spring Harb Perspect Biol, 2016, 8(5)：a021873.
|
| [33] |
Andrews JP, Marttala J, Macarak E, et al. Keloids: the paradigm of skin fibrosis - Pathomechanisms and treatment[J]. Matrix Biol, 2016, 51: 37-46.
|
| [34] |
Piersma B, Bank RA, Boersema M. Signaling in fibrosis: TGF-beta, WNT, and YAP/TAZ converge[J]. Front Med (Lausanne), 2015, 2: 59.
|
| [35] |
Fujii M, Toyoda T, Nakanishi H, et al. TGF-beta synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth[J]. J Exp Med, 2012, 209(3): 479-494.
|
| [36] |
Qin Z, Xia W, Fisher GJ, et al. YAP/TAZ regulates TGF-beta/Smad3 signaling by induction of Smad7 via AP-1 in human skin dermal fibroblasts[J]. Cell Commun Signal, 2018, 16(1): 18.
|
| [37] |
伍倩，谭晓宇，王怡佳，等. Wnt/ β连环蛋白信号通路在体表创面愈合中的作用机制研究进展[J]. 中华烧伤与创面修复杂志，2023, 39(2): 190-195.
|
| [38] |
Igota S, Tosa M, Murakami M, et al. Identification and characterization of Wnt signaling pathway in keloid pathogenesis[J]. Int J Med Sci, 2013, 10(4): 344-354.
|
| [39] |
Imajo M, Miyatake K, Iimura A, et al. A molecular mechanism that links Hippo signalling to the inhibition of Wnt/beta-catenin signalling[J]. EMBO J, 2012, 31(5): 1109-1122.
|